Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:birthPlace |
gptkb:New_York_City
|
| gptkbp:boardMemberOf |
gptkb:Axovant_Sciences
gptkb:Nuvation_Bio |
| gptkbp:education |
gptkb:Harvard_Medical_School
gptkb:Harvard_University |
| gptkbp:field |
gptkb:biotechnology
oncology |
| https://www.w3.org/2000/01/rdf-schema#label |
David Hung
|
| gptkbp:knownFor |
founding Medivation
|
| gptkbp:nationality |
gptkb:American
|
| gptkbp:notableWork |
development of enzalutamide (Xtandi)
|
| gptkbp:occupation |
gptkb:physician
biotech entrepreneur |
| gptkbp:position |
founder and CEO of Medivation
|
| gptkbp:bfsParent |
gptkb:Medivation
|
| gptkbp:bfsLayer |
5
|